Vertex currently operates at the forefront of rare disease scientific innovation and has successfully developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF), Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia and Acute Pain. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases including programs in Type 1 diabetes, IgA Nephropathy (IgAN), APOL-1 Mediated Kidney Disease, among others. The Director, Market Access Strategy Lead – AMKD (inaxaplin) is accountable for leading and overseeing the development of Market Access (MA) strategies, tactical support programs and overall execution of access resources across all payer channels for the commercialization of inaxaplin. This role requires a significant degree of collaboration, influencing and driving strategic alignment across multiple functions (Account Management, Trade, Pricing & Contracting, US Public Affairs, HEOR, New Product Planning, Global Value & Access Strategy (GVAS), and Marketing). A few core elements include the development of the value proposition and PIE resources.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director